Axsome Therapeutics, a biopharmaceutical company specializing in central nervous system disorders, announced its participation in several investor conferences throughout November 2026, including events in Boston, New York, and London. The company will hold fireside chats and investor meetings to discuss its portfolio and ongoing developments. Live webcasts of key presentations will be available on Axsome's website, providing broader access to investors. This engagement aims to update stakeholders on Axsome's progress and future plans in CNS treatment innovation.
Axsome Therapeutics' upcoming investor conferences provide context for readers interested in health sector trends. For readers following health-sector stocks on Pluang, here is the market snapshot as of Nov 03, 2026 19:02 WIB: out of 150 priced US health stocks, 74 rose and 69 fell. Notable movers include AHCO at USD 6.20 with a 1-day change of +4.91%, NUVB at USD 4.81 up +4.79%, and ACB at USD 4.40 with a +4.27% increase.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
